MONJUVI

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 73535-208
  • Package NDC 73535-208-01
  • Application number BLA761163
  • SPL ID 49d73fc8-03e2-8b9c-e063-6294a90a3a97
  • SPL set ID ec13ac6b-bfde-4e84-907a-83bd69584d95
  • UNII QQA9MLH692
  • RxCUI 2387338
  • RxCUI 2387343

What the source publishes

Labeler
Incyte Corporation
Active ingredients
Tafasitamab-cxix
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:73535-208_49d73fc8-03e2-8b9c-e063-6294a90a3a97
{
  "name": "MONJUVI",
  "splId": "49d73fc8-03e2-8b9c-e063-6294a90a3a97",
  "labels": [
    {
      "setId": "ec13ac6b-bfde-4e84-907a-83bd69584d95",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec13ac6b-bfde-4e84-907a-83bd69584d95",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec13ac6b-bfde-4e84-907a-83bd69584d95"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Incyte Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL in 1 CARTON (73535-208-01)  / 5 mL in 1 VIAL",
      "package_ndc": "73535-208-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200805"
    }
  ],
  "productId": "73535-208_49d73fc8-03e2-8b9c-e063-6294a90a3a97",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "73535-208",
  "deaSchedule": null,
  "genericName": "Tafasitamab-cxix",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TAFASITAMAB",
      "strength": "200 mg/5mL"
    }
  ],
  "applicationNumber": "BLA761163",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200805",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0373535208013"
    ],
    "unii": [
      "QQA9MLH692"
    ],
    "rxcui": [
      "2387338",
      "2387343"
    ],
    "spl_set_id": [
      "ec13ac6b-bfde-4e84-907a-83bd69584d95"
    ],
    "manufacturer_name": [
      "Incyte Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:73535-208_49d73fc8-03e2-8b9c-e063-6294a90a3a97"